Will Conway is Co-Founder, CTO, and Lead Clinical QP for Rexpharma Ltd. He has over 21 years' Quality experience at Shire, Pfizer, and Emergent BioSolutions. More recently as the Head of Quality/Regulatory at Adapt Pharma, he launched Narcan Nasal Spray in the US and Canada leading the fight against the opioid pandemic. Having co-founded Rexpharma in 2023, he is providing a novel service to Clinical Sponsors for the QP release of the Sponsors IMP to EU and global clinical trials as a clinical service. See www.rexpharma.ie for more details on QP releases, quality audits, and QP declarations for Sponsors.